TDP-43 Research Tracker

TDP-43, explained — and what's being tested against it

A calm, sourced tracker of research on TDP-43, the protein that goes wrong in nearly all cases of ALS. Plain English first; the science is one tap away.

See the therapy pipeline →

Healthy neuronTwo panels. Left, a healthy neuron: many TDP-43 molecules inside the nucleus bound to RNA strands, a few passing through nuclear pores and a few in the cytoplasm. Right, a neuron in ALS: the nucleus is nearly empty of TDP-43, large irregular phosphorylated TDP-43 clumps sit in the cytoplasm, and a callout shows STMN2 or UNC13A RNA with an extra cryptic exon inserted, leading to less protein.Healthy neuronSTMN2 / UNC13A RNA→ normal protein
  • Nucleus
  • nuclear pore
  • TDP-43
  • RNA
TDP-43 stays in the nucleus, helping process RNA.
In ALSTwo panels. Left, a healthy neuron: many TDP-43 molecules inside the nucleus bound to RNA strands, a few passing through nuclear pores and a few in the cytoplasm. Right, a neuron in ALS: the nucleus is nearly empty of TDP-43, large irregular phosphorylated TDP-43 clumps sit in the cytoplasm, and a callout shows STMN2 or UNC13A RNA with an extra cryptic exon inserted, leading to less protein.In ALSPPPSTMN2 / UNC13A RNAcryptic exon→ less protein
  • TDP-43 depleted
  • TDP-43 clumps
  • P = phosphorylated
  • TDP-43
TDP-43 leaves the nucleus and forms clumps; RNA is mis-spliced.

What is TDP-43?

TDP-43 is a protein your cells make from a gene called TARDBP[1]. Normally it lives in the cell's nucleus (its control center), where it grabs onto RNA — the working copies of genes — and helps edit them correctly.

In ALS, TDP-43 leaves the nucleus and clumps together in the surrounding cell. This was discovered in 2006[2]. Those clumps are found in about 97% of people with ALS and about 45% of people with frontotemporal dementia (FTD)[3]. That includes most people with ALS who have no known genetic cause.

So there are two problems: the clumps may be toxic, and the nucleus loses TDP-43's editing work. When that editing stops, some genes pick up junk pieces called cryptic exons[4]. Two important examples:

Because these broken pieces show up only when TDP-43 isn't working, researchers are using them both as biomarkers (signs you can measure) and as drug targets: several drugs now in trials try to put STMN2 or UNC13A back.

Deeper dive: the molecular details
Hand-drawn sketch of TDP-43: a small head domain, two RNA-binding loops holding an RNA strand, and a wiggly tail head (NTD)RRM1RRM2tailRNA
TDP-43’s parts: an N-terminal domain (NTD), two RNA-binding motifs (RRM1, RRM2) and a disordered C-terminal tail where most ALS mutations sit. Simplified sketch, not to scale.

TDP-43 (TAR DNA-binding protein 43) is a 414-amino-acid heterogeneous nuclear ribonucleoprotein encoded by TARDBP on chromosome 1[1]. It has an N-terminal domain that self-associates, two RNA-recognition motifs (RRM1, RRM2) that bind UG-rich RNA, and a C-terminal low-complexity (prion-like) domain where most disease mutations cluster[9].

In ALS/FTLD-TDP, TDP-43 is depleted from the nucleus and forms cytoplasmic inclusions that are hyperphosphorylated, ubiquitinated and cleaved into C-terminal fragments[2]. Dominant TARDBP mutations cause a small fraction of familial ALS[9], showing that TDP-43 dysfunction can be causal, not just a bystander.

Loss of nuclear TDP-43 de-represses poorly conserved cryptic exons[4]. In STMN2, a cryptic exon in intron 1 with a premature polyadenylation site produces a truncated transcript and loss of stathmin-2[5][6]. In UNC13A, cryptic exon inclusion triggers nonsense-mediated decay; ALS/FTD risk SNPs in the same intron potentiate inclusion[7][8]. Antisense oligonucleotides that block these cryptic splice sites are in clinical trials (see the pipeline).

The numbers “~97% of ALS / ~45% of FTD” are autopsy-based estimates summarized by Ling, Polymenidou & Cleveland (2013)[3]. Exceptions include SOD1- and FUS-related ALS, which usually lack TDP-43 inclusions.

What's new

See all updates →

On this site

Sources

  1. NCBI Gene: TARDBP (Gene ID 23435)
  2. Neumann et al., Science 2006 (PMID 17023659)
  3. Ling, Polymenidou & Cleveland, Neuron 2013 (PMID 23931993)
  4. Ling et al., Science 2015 (PMID 26250685)
  5. Klim et al., Nat Neurosci 2019 (PMID 30643292)
  6. Melamed et al., Nat Neurosci 2019 (PMID 30643298)
  7. Ma et al., Nature 2022 (PMID 35197626)
  8. Brown et al., Nature 2022 (PMID 35197628)
  9. Sreedharan et al., Science 2008 (PMID 18309045)